Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_assertion type Assertion NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_head.
- NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_assertion description "[The aim of this study was to investigate interleukin 4 (IL4), Angiotensin Converting Enzyme (ACE), C-C Chemocine Receptor 5 (CCR5), Cytotoxic T Lymphocyte-associated Antigen Receptor 4 (CTLA4) and Interleukin 1 Receptor Antagonist (IL1-RN) gene polymorphisms in 48 Turkish vitiligo patients and 50 healthy controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_provenance.
- NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_assertion evidence source_evidence_literature NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_provenance.
- NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_assertion SIO_000772 19129082 NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_provenance.
- NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_assertion wasDerivedFrom befree-20140225 NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_provenance.
- NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_assertion wasGeneratedBy ECO_0000203 NP212420.RAcwAkTB9Im111V5vWROCkM_2kym1J7hAtNDvIsHtvUIE130_provenance.